271 related articles for article (PubMed ID: 24462217)
1. Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.
Cortese A; Plagnol V; Brady S; Simone R; Lashley T; Acevedo-Arozena A; de Silva R; Greensmith L; Holton J; Hanna MG; Fisher EM; Fratta P
Neurobiol Aging; 2014 Jun; 35(6):1491-8. PubMed ID: 24462217
[TBL] [Abstract][Full Text] [Related]
2. Optineurin is potentially associated with TDP-43 and involved in the pathogenesis of inclusion body myositis.
Yamashita S; Kimura E; Tawara N; Sakaguchi H; Nakama T; Maeda Y; Hirano T; Uchino M; Ando Y
Neuropathol Appl Neurobiol; 2013 Jun; 39(4):406-16. PubMed ID: 22860700
[TBL] [Abstract][Full Text] [Related]
3. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy.
Seelen M; Visser AE; Overste DJ; Kim HJ; Palud A; Wong TH; van Swieten JC; Scheltens P; Voermans NC; Baas F; de Jong JM; van der Kooi AJ; de Visser M; Veldink JH; Taylor JP; Van Es MA; van den Berg LH
Neurobiol Aging; 2014 Aug; 35(8):1956.e9-1956.e11. PubMed ID: 24612671
[TBL] [Abstract][Full Text] [Related]
4. [TDP-43 proteinopathies - from frontotemporal lobar degeneration to inclusion body myositis].
Kierdaszuk B; Berdyński M; Zekanowski C; Kamińska A
Neurol Neurochir Pol; 2012; 46(4):384-91. PubMed ID: 23023438
[TBL] [Abstract][Full Text] [Related]
5. The proteinopathy of D169G and K263E mutants at the RNA Recognition Motif (RRM) domain of tar DNA-binding protein (tdp43) causing neurological disorders: A computational study.
Bhandare VV; Ramaswamy A
J Biomol Struct Dyn; 2018 Mar; 36(4):1075-1093. PubMed ID: 28330421
[TBL] [Abstract][Full Text] [Related]
6. Abnormal distribution of heterogeneous nuclear ribonucleoproteins in sporadic inclusion body myositis.
Pinkus JL; Amato AA; Taylor JP; Greenberg SA
Neuromuscul Disord; 2014 Jul; 24(7):611-6. PubMed ID: 24857366
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of TDP-43 Proteinopathy Onset and Propagation.
Chen HJ; Mitchell JC
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199367
[TBL] [Abstract][Full Text] [Related]
8. Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment.
Andrés-Benito P; Gelpi E; Jové M; Mota-Martorell N; Obis È; Portero-Otin M; Povedano M; Pujol A; Pamplona R; Ferrer I
Neuropathol Appl Neurobiol; 2021 Jun; 47(4):544-563. PubMed ID: 33332650
[TBL] [Abstract][Full Text] [Related]
9. Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD.
Hayes LR; Kalab P
Neurotherapeutics; 2022 Jul; 19(4):1061-1084. PubMed ID: 35790708
[TBL] [Abstract][Full Text] [Related]
10. TDP43 and RNA instability in amyotrophic lateral sclerosis.
Weskamp K; Barmada SJ
Brain Res; 2018 Aug; 1693(Pt A):67-74. PubMed ID: 29395044
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic mislocalization of RNA splicing factors and aberrant neuronal gene splicing in TDP-43 transgenic pig brain.
Wang G; Yang H; Yan S; Wang CE; Liu X; Zhao B; Ouyang Z; Yin P; Liu Z; Zhao Y; Liu T; Fan N; Guo L; Li S; Li XJ; Lai L
Mol Neurodegener; 2015 Sep; 10():42. PubMed ID: 26334913
[TBL] [Abstract][Full Text] [Related]
12. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia.
Archbold HC; Jackson KL; Arora A; Weskamp K; Tank EM; Li X; Miguez R; Dayton RD; Tamir S; Klein RL; Barmada SJ
Sci Rep; 2018 Mar; 8(1):4606. PubMed ID: 29545601
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal full-length antibody against TAR DNA binding protein 43 reduces related proteinopathy in neurons.
Pozzi S; Codron P; Soucy G; Renaud L; Cordeau PJ; Dutta K; Bareil C; Julien JP
JCI Insight; 2020 Nov; 5(21):. PubMed ID: 33021970
[TBL] [Abstract][Full Text] [Related]
14. Targeted sequencing and identification of genetic variants in sporadic inclusion body myositis.
Weihl CC; Baloh RH; Lee Y; Chou TF; Pittman SK; Lopate G; Allred P; Jockel-Balsarotti J; Pestronk A; Harms MB
Neuromuscul Disord; 2015 Apr; 25(4):289-96. PubMed ID: 25617006
[TBL] [Abstract][Full Text] [Related]
15. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
Ratti A; Buratti E
J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
[TBL] [Abstract][Full Text] [Related]
16. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
Jovičić A; Paul JW; Gitler AD
J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
[TBL] [Abstract][Full Text] [Related]
17. TDP43 pathology in the brain, spinal cord, and dorsal root ganglia of a patient with FOSMN.
Rossor AM; Jaunmuktane Z; Rossor MN; Hoti G; Reilly MM
Neurology; 2019 Feb; 92(9):e951-e956. PubMed ID: 30700593
[TBL] [Abstract][Full Text] [Related]
18. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.
Nalbandian A; Donkervoort S; Dec E; Badadani M; Katheria V; Rana P; Nguyen C; Mukherjee J; Caiozzo V; Martin B; Watts GD; Vesa J; Smith C; Kimonis VE
J Mol Neurosci; 2011 Nov; 45(3):522-31. PubMed ID: 21892620
[TBL] [Abstract][Full Text] [Related]
19. RNA methylation influences TDP43 binding and disease pathogenesis in models of amyotrophic lateral sclerosis and frontotemporal dementia.
McMillan M; Gomez N; Hsieh C; Bekier M; Li X; Miguez R; Tank EMH; Barmada SJ
Mol Cell; 2023 Jan; 83(2):219-236.e7. PubMed ID: 36634675
[TBL] [Abstract][Full Text] [Related]
20. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation.
Tziortzouda P; Van Den Bosch L; Hirth F
Nat Rev Neurosci; 2021 Apr; 22(4):197-208. PubMed ID: 33654312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
